Overexpression of BCL-xL Promotes Chemotherapy Resistance of Mammary Tumors in a Syngeneic Mouse Model

American Journal of Pathology - United States
doi 10.1016/s0002-9440(10)65505-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cooperation of BCL-xL and C-Myc in Mammary Tumorigenesis

1999English

Genetic Determinants of Response to Chemotherapy in Transgenic Mouse Mammary and Salivary Tumors

Oncogene
Cancer ResearchGeneticsMolecular Biology
2000English

Metabolomic Changes Accompanying Transformation and Acquisition of Metastatic Potential in a Syngeneic Mouse Mammary Tumor Model

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

BCL-xL Promotes Metastasis Independent of Its Anti-Apoptotic Activity

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2016English

Inhibition of Hemangioma Development in a Syngeneic Mouse Model Correlates With BCL-2 Suppression and the Inhibition of Akt Kinase Activity

Angiogenesis
Cancer ResearchClinical BiochemistryPhysiology
2011English

Development of a Syngeneic Mouse Model of Epithelial Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2010English

Alcohol Consumption Suppresses Mammary Tumor Metastasis in a Syngeneic Tumor Transplantation Model

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

Ets2-Dependent Microenvironmental Support of Mouse Mammary Tumors

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

BCL-xL in Neuroprotection and Plasticity

Frontiers in Physiology
Physiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy